Movers Archives - Page 199 of 2348

2 minute read

Why Is New York Times Stock Trading Higher On Wednesday?

May 8, 2:56 PM

New York Times' digital subscribers hit 9.91 million, growing by 210K in Q1. Sales reached $594M, up 5.9% Y/Y. Digital ARPU rose to $9.21. CEO Meredith Kopit Levien emphasizes a strong start in 2024. Guidance predicts subscription revenues up by 6%-8% in Q2.

NYT

2 minute read

Upstart Nearing Inflection Point? 2 Analysts Examine Opportunities And Challenges Post-Q1 Earnings

By Nabaparna Bhattacharya

May 8, 2:48 PM

Upstart reports Q1 revenue beat but issues lower Q2 guidance; analysts assess potential inflection point amid earnings season.

UPST

3 minute read

ZoomInfo Technologies Stock Dives On Heels Of Q1 Earnings: ‘Investors Need To Carefully Monitor The Macro’

By Priya Nigam

May 8, 2:42 PM

Investors "will need to carefully monitor the macro to understand if ZoomInfo can hit their FY guide in the 2H," one analyst said.

2 minute read

Globus Medical Shares Race Higher After Better-Than-Expected Q1 Results

By Erica Kollmann

May 8, 2:31 PM

Globus Medical reported quarterly earnings of 72 cents per share which beat the analyst consensus estimate of 57 cents by 26.32% and represents a 35.85% increase over earnings from the same period last year. Quarterly sales came in at $606.67 million which beat the analyst consensus estimate by 3.33% and is a 119.26% increase in sales year-over-year.

GMED

2 minute read

Elanco Animal Health’s Q1 Earnings Show Improved Base Business, Analyst Highlights Slightly Delayed But Encouraging Pipeline

By Vandana Singh

May 8, 2:28 PM

Elanco Animal Health (NYSE: ELAN) reports Q1 results: adjusted EPS $0.34 (-26% Y/Y), sales $1.21B (-4% Y/Y). 2024 guidance: EPS $0.88-$0.96, revenue $4.46-$4.52 billion.

ELAN

2 minute read

Coupang Shares Fall After Mixed Q1 Results: Here’s Why

By Erica Kollmann

May 8, 2:25 PM

Coupang reported quarterly earnings of 5 cents per share which missed the analyst consensus estimate of 6 cents per share, unchanged from the same period last year. Quarterly sales clocked in at $7.11 billion which beat the analyst consensus estimate of $6.91 billion and represents a 22.66% increase over sales of $5.8 billion from the same period last year.

CPNG

2 minute read

What’s Going On With Ingredion Shares After Q1 Results?

By Nabaparna Bhattacharya

May 8, 2:00 PM

Ingredion shares edge up despite $51M charges from South Korean business sale, as Q1 earnings beat but revenues miss expectations.

INGR

2 minute read

Uber Stock Dips 9% After Q1 Earnings, JPMorgan Analyst Says Pullback Overdone

By Nabaparna Bhattacharya

May 8, 2:00 PM

Uber is expected to grow the Delivery category profitably as it looks to improve network efficiencies and scale advertising.

UBER

1 minute read

What’s Going On With United Parks & Resorts Shares Wednesday?

By Nabaparna Bhattacharya

May 8, 1:50 PM

United Parks & Resorts reported quarterly earnings per share of 17 cents loss, which beats the analyst consensus of 27 cents loss.

PRKS

2 minute read

Generics Player Teva Pharmaceutical Aces Late-Stage Schizophrenia Drug Study, Stock Shoots Higher

By Vandana Singh

May 8, 1:49 PM

Results from the Phase 3 SOLARIS trial of TEV-‘749 for schizophrenia treatment. SteadyTeq technology ensures controlled olanzapine release. Clinically meaningful improvements in PANSS scores observed across dosing groups.

TEVA